Waldenstrom Macroglobulinaemia
8 clinical trials · Condition
◉ Watch Waldenstrom Macroglobulinaemia
| Record | Firm | Date |
|---|---|---|
| A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies (NCT01805375) | Cancer Research UK | 2013-04-01 |
| A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia (NCT00811733) | GlaxoSmithKline | 2009-03-01 |
Track Waldenstrom Macroglobulinaemia automatically
Every clearance here is in the API, with alerts when new ones post.